|
Chikujee Therapeutics is an innovative
biopharmaceutical company with an emphasis on the preclinical and early
clinical development of novel or modified target specific delivery
systems.
The core competency of Chikujee is development of novel site specific
delivery systems for proprietary and biosimilar biopharmaceuticals. We
have considerable expertise in the application of our proprietary target
site specific delivery technologies to a range of compounds and
materials for potential therapeutic benefit. Our strategy going forward
is designed to exploit these capabilities both in collaboration with
established companies and for the creation of the Company's own internal
pipeline.
We work with established companies to develop new delivery modes
Enhance dosage
forms for new and existing drugs and compounds (proprietary and
biosimilar).
We develop our
internal drug candidates through to phase I/II.
License these
opportunities to Bio Pharmaceutical partners.
We believe many aspects of our technologies are not
readily reproduced, and they impart unique
properties to drugs that can not be matched by any
other currently available process.
We invite conversations with interested parties to
discuss their drug delivery needs and our capabilities to meet those
needs.
|
